Table 1. A summary of FFPE leiomyosarcoma cases included in this study.
Case | Anatomical Site | Tumour Sampling Date | Age of Sample at Analysis | DLR Spread |
LMS 1 | Bowel | 2010 | 1 | 0.24 |
LMS 2 | Lower Limb | 2011 | 1 | 0.21 |
LMS 3 | Lower Limb | 2011 | 1 | 0.17 |
LMS 4 | Bladder | 2011 | 1 | 0.17 |
LMS 5 | Stomach | 2011 | 1 | 0.23 |
LMS 6 | Stomach | 1994 | 17 | 0.25 |
LMS 7 | Lower Limb | 1999 | 12 | 0.26 |
LMS 8 | Bladder | 1998 | 13 | 0.21 |
LMS 9§ | Vagina | 2011 | 1 | 0.25 |
LMS 10§ | Retroperitoneum | 2011 | 1 | 0.29 |
LMS 11§ | Pelvis | 2011 | 1 | 0.34 |
LMS 12 | Stomach | 2011 | 1 | 0.26 |
LMS 13 | Uterus | 2004 | 8 | 0.40 |
LMS 14 | Bowel | 1995 | 17 | 0.32 |
LMS 15 | Uterus | 1997 | 15 | 0.35 |
LMS 16 | Uterus | 1997 | 15 | 0.33 |
LMS 17 | Nose | 1998 | 14 | 0.26 |
LMS 18 | Pelvis | 2004 | 8 | 0.21 |
LMS 19 | Retroperitoneum | 2003 | 9 | 0.23 |
LMS 20 | Uterus | 2008 | 4 | 0.21 |
LMS 21 | Uterus | 2011 | 1 | 0.17 |
LMS 22 | Lower Limb | 2000 | 12 | 0.27 |
DLR Spread – Derivative Log Ratio Spread of Array Data.
Additional fresh samples obtained and frozen before fixing in formalin.